Ambadnya Life Science LLP Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Ambadnya Life Science LLP Pharmaceutical Export Portfolio Dataset — 2 Products, $86.4K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Ambadnya Life Science LLP — Pharmaceutical Exporter Profile (2026) | 2 Products, $86.4K Trade | TransData Nexus

Ambadnya Life Science LLP

Indian Pharmaceutical Exporter · Antimalarial & Antiparasitic Specialist · $86.4K Total Trade · DGFT Verified

Ambadnya Life Science LLP is an Indian pharmaceutical exporter with a total trade value of $86.4K across 2 products in 2 therapeutic categories. Based on 7 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Levamisole ($58.8K), Ibuprofen Paracetamol ($27.7K), .

Ambadnya Life Science LLP — Export Portfolio & Destination Treemap

Ambadnya Life Science LLP pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Ambadnya Life Science LLP? — Company Overview & Market Position

Ambadnya Life Science LLP is an Indian pharmaceutical exporter specializing in the development and manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established on December 15, 2016, in Boisar, Maharashtra, the company operates under the Corporate Identification Number (CIN) AAI-0150. The registered office is located at Plot No C-9/1, MIDC Tarapur, Boisar, Maharashtra, India, 401506. The company is led by Designated Partners Nutan Rajesh Tiwari and Rajesh Ramavtar Tiwari, with Hansaraj Kamlaprasad Gupta serving as a director. Ambadnya Life Science LLP is committed to delivering quality pharmaceutical products worldwide, adhering to the WHO-GMP standards.

What Does Ambadnya Life Science LLP Export? — Product Portfolio Analysis

Top Products by Export Value

1Levamisole$58.8K 2Ibuprofen Paracetamol$27.7K

Product Portfolio — Top 2 by Export Value

Ambadnya Life Science LLP exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Levamisole	Antimalarial & Antiparasitic	$58.8K	4	2.2%	9
2	Ibuprofen Paracetamol	Combination Drugs	$27.7K	3	1.4%	6

Ambadnya Life Science LLP exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $86.4K. The top category is Antimalarial & Antiparasitic (68.0% of portfolio), followed by Combination Drugs (32.0%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Ambadnya Life Science LLP — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

The company's manufacturing facility is situated in Boisar, Maharashtra, within the MIDC Tarapur industrial area. This location is strategically chosen to leverage the region's industrial infrastructure and proximity to key markets. The facility is equipped with fully automated equipment and ultra-modern facilities, ensuring compliance with Current Good Manufacturing Practices (CGMP). While specific production capacities and specializations are not publicly disclosed, the company's focus on quality and adherence to international standards underscore its commitment to excellence in pharmaceutical manufacturing.

3Key Leadership

Ambadnya Life Science LLP is guided by a team of experienced leaders:

Nutan Rajesh Tiwari: Designated Partner since December 15, 2016.

Rajesh Ramavtar Tiwari: Designated Partner since December 15, 2016.

Hansaraj Kamlaprasad Gupta: Director since May 3, 2017.

These leaders bring a wealth of experience to the company, steering its strategic direction and operational excellence.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Ambadnya Life Science LLP Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Ambadnya Life Science LLP's export portfolio, valued at $86,000 USD over seven shipments, includes two products across two therapeutic categories. The top products are Levamisole ($59,000 USD) and Ibuprofen Paracetamol ($28,000 USD), with market shares of 2.2% and 1.4%, respectively. The primary therapeutic categories are Antimalarial & Antiparasitic (68.0%) and Combination Drugs (32.0%). The company's focus on these categories suggests a strategic alignment with global health priorities, particularly in regions where these treatments are in demand. However, specific details regarding regulatory filings, approvals, and market access status in the US, EU, UK, Australia, and Japan are not publicly available. This lack of publicly disclosed information may indicate that the company is in the early stages of entering these markets or has not yet pursued regulatory approvals in these regions.

2Emerging Markets

Ambadnya Life Science LLP has demonstrated a presence in emerging markets, notably in Africa and Latin America. The company's export data indicates shipments to countries such as the Democratic Republic of the Congo and the Republic of the Congo. While specific details about WHO prequalification are not available, the company's adherence to WHO-GMP standards suggests a commitment to meeting international quality benchmarks, which is essential for accessing and expanding in these emerging markets.

Ambadnya Life Science LLP — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Ambadnya Life Science LLP's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not publicly available. This lack of publicly disclosed information may indicate that the company has not pursued FDA approvals or registrations for its products. For importers and partners, it is advisable to verify the company's compliance with FDA regulations and approvals before engaging in business transactions.

2WHO & EU GMP

Ambadnya Life Science LLP's commitment to quality is evidenced by its adherence to WHO-GMP standards. The company's manufacturing facility is equipped with fully automated equipment and ultra-modern facilities, ensuring compliance with Current Good Manufacturing Practices (CGMP). However, specific certifications such as WHO prequalification, EU GMP certificates, and EDQM status are not publicly disclosed. Importers and partners should verify the company's certifications and compliance with international quality standards before proceeding with business engagements.

3CDSCO & Indian Regulatory

Ambadnya Life Science LLP — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Ambadnya Life Science LLP operates in the competitive pharmaceutical export market, focusing on Antimalarial & Antiparasitic and Combination Drugs. While specific competitors in these therapeutic categories are not identified, the company's export data indicates a presence in markets such as the Democratic Republic of the Congo and the Republic of the Congo. The company's focus on quality, adherence to WHO-GMP standards, and strategic product portfolio may provide a competitive edge in these regions. However, the limited number of shipments and market share suggest that the company is in the early stages of establishing its presence in these markets.

2Key Differentiators

Ambadnya Life Science LLP's key differentiators include its commitment to quality, adherence to WHO-GMP standards, and focus on specific therapeutic categories such as Antimalarial & Antiparasitic and Combination Drugs. The company's manufacturing facility is equipped with fully automated equipment and ultra-modern facilities, ensuring compliance with Current Good Manufacturing Practices (CGMP). These factors contribute to the company's ability to deliver high-quality pharmaceutical products to international markets.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Ambadnya Life Science LLP as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Ambadnya Life Science LLP has demonstrated a presence in international markets, with export data indicating shipments to countries such as the Democratic Republic of the Congo and the Republic of the Congo. The company's focus on quality, adherence to WHO-GMP standards, and strategic product portfolio suggest a commitment to reliability and consistency. However, the limited number of shipments and market share indicate that the company is in the early stages of its export operations. Importers and partners should conduct thorough due diligence to assess the company's track record, export volume, and consistency before engaging in business transactions.

2Certifications to Verify

Importers should verify the following certifications before engaging with Ambadnya Life Science LLP:

WHO-GMP Certification: To ensure compliance with international manufacturing standards.

EU GMP Certification: To confirm adherence to European Union manufacturing standards.

Frequently Asked Questions — Ambadnya Life Science LLP

How many pharmaceutical products does Ambadnya Life Science LLP export from India?

Ambadnya Life Science LLP exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Levamisole ($58.8K), Ibuprofen Paracetamol ($27.7K). Total export value is $86.4K.

What is Ambadnya Life Science LLP's total pharmaceutical export value?

Ambadnya Life Science LLP's total pharmaceutical export value is $86.4K, based on 7 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Ambadnya Life Science LLP cover?

Ambadnya Life Science LLP exports across 2 therapeutic categories. The largest are Antimalarial & Antiparasitic (68.0%, 1 products), Combination Drugs (32.0%, 1 products).

Get Full Ambadnya Life Science LLP Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.